Developing safe and effective contraceptive agents for men and women
BIOLOGICAL TESTING FACILITY - STABILITY TESTING, CLINICAL FORMULATION DEVELOPMENT AND MANUFACTURING ACTIVITIES OF CONTRACEPTIVE AGENTS
This study is exploring new ways to prevent pregnancy by looking at how certain drugs can affect ovulation and sperm, and it's aimed at helping people who want better contraceptive options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-10618518 on NIH RePORTER |
What this research studies
This research focuses on creating new contraceptive methods by disrupting normal ovulation and sperm function. It involves the Biological Testing Facility, which evaluates new drug formulations and delivery systems through various preclinical activities, including in vitro and in vivo assays. The facility also conducts studies on the absorption, metabolism, and toxicity of these compounds, with the goal of advancing them to human trials. Non-human primates are used to test these contraceptive agents before they are considered for human use.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals seeking new contraceptive methods or those interested in participating in clinical trials for contraceptive agents.
Not a fit: Patients who are not interested in contraceptive methods or who have contraindications to hormonal or non-hormonal contraceptive agents may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new, safe, and affordable contraceptive options for both men and women.
How similar studies have performed: Previous research in contraceptive development has shown promise, indicating that innovative approaches can lead to successful new contraceptive methods.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Burnin, Debra — Sri International
- Study coordinator: Burnin, Debra
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.